Skip to Content
Investing Specialists

Weekly Wrap: How the Pandemic Has Changed the Math on Emergency Funds and College Savings

We recap the week on Morningstar.com and note the most popular stocks, funds, and exchange-traded funds.

Editor's note: Read the latest on how the coronavirus is rattling the markets and what investors can do to navigate it.

Editor's Picks
Why Become an ESG Investor?
The question is not rhetorical.

Stakeholder Votes Divided on Social Justice
Proxy voting reveals disagreement between the influential majority and smaller shareholders on diversity, equity, and inclusion issues.

529 College Savings Plans During the Pandemic
Here's how they've been performing and what college savers should be thinking about today.

How Can Advisors Help Clients Through Market Anxiety?
Our research explored three tactics for dissuading client fears about increased volatility.

The New Math on Emergency Funds
Don't eat that first potato chip.

Portfolio Planning and Personal Finance With Christine Benz
Ramit Sethi: 'Question What You’ve Been Told About Buying a House'
The author of the best-selling book, "I Will Teach You to Be Rich," on how homeownership fits into a financial plan.

Mutual Funds and Exchange-Traded Funds
What Top Fund Managers Are Buying and Selling
Across the board, Morningstar Medalists got defensive in the third quarter.

Stocks
Electricity Demand's COVID Comeback
Utilities should benefit as the U.S. economy electrifies.

What Is Gold Worth?
And do any other assets currently compare?

Our Ultimate Stock-Pickers' Top 10 High-Conviction Purchases
Several funds see value in basic materials and industrials.

There’s Still Gas in Ford’s Tank
The legendary pony takes on Tesla and aims for pole position on profitability.

Stock Analyst Updates
Astra and Oxford Report Strong COVID-19 Vaccine
Astra’s vaccine looks potentially easier to transport with only mild temperature requirements as compared with the other vaccines.

Regeneron Authorized to Use Antibody Cocktail
We're maintaining our $500 fair value estimate for the narrow-moat drug manufacturer.

Advisor Insights 
Building a Niche Advisory Firm From the Ground Up
Knowing your customer is critical.

Most Requested Stock Quotes
Apple
Tesla
Pfizer
Intel
Amazon.com

Most Requested Fund Quotes
Vanguard 500 Index
Vanguard Dividend Growth
T. Rowe Price Blue Chip Growth
Fidelity 500 Index
Fidelity Contrafund

Most Requested ETF Quotes 
ARK Innovation ETF
Invesco QQQ Trust
SPDR S&P 500 ETF
Vanguard Total Stock Market ETF
Vanguard S&P 500 ETF

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.